Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DYNAVAX TECHNOLOGIES CORP Director's Dealing 2022

Feb 14, 2022

32130_dirs_2022-02-14_188284bc-7a2a-4c24-b891-ed6823ccb542.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2022-02-10

Reporting Person: MacDonald Kelly (SVP and CFO)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-02-10 Stock Option (Right to Buy) $12.74 A 90500 Acquired 2029-02-09 Common Stock (90500) Direct
2022-02-10 Restricted Stock Unit $ A 16000 Acquired Common Stock (16000) Direct

Footnotes

F1: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of February 10, 2022, and one thirty-sixth (1/36) of the shares
subject to the option vesting each month thereafter.

F2: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of February 10, 2022